Medtech developing biomorphic programmable polymers for tissue reconstruction
| Date | Round | Amount |
|---|---|---|
| May 2023 | Funding round French medtech Tissium received an investment from the Fonds Stratégique des Transitions. | — |
| May 2023 | Series D Plus TISSIUM closed a EUR50M Series D from investors including ISALT, Merieux Developpement, Cathay Health, Credit Mutuel Innovation and Sofinnova Partners. | $54M |
| Aug 2021 | Series C Paris medtech Tissium raised a EUR 50M Series C led by Cathay Health to commercialise its tissue-reconstruction polymers. | $59M |